文献速递妇科

非雌激素疗法治疗绝经生殖泌尿综合征的系统综述

Nonestrogen Therapies for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review.
PubMed 文献 · Obstet Gynecol · 2023-08-04

该研究系统检索了MEDLINE、EMBASE、ClinicalTrials.gov和Cochrane数据库(建库至2021年7月),纳入136项研究,评估七种非雌激素产品治疗绝经生殖泌尿综合征的效果。多数非雌激素疗法对绝经生殖泌尿综合征各症状有效,但非雌激素方案之间比较数据不足。

要点

  • 阴道脱氢表雄酮、奥培米芬、激光或能量疗法、聚卡波非阴道保湿剂、替勃龙、透明质酸和睾酮均可改善萎缩的主观和客观体征。
  • 阴道脱氢表雄酮、奥培米芬、替勃龙、点阵二氧化碳激光、聚卡波非阴道保湿剂和睾酮可改善性功能。
  • 非雌激素替代疗法与雌激素或安慰剂相似或更优,不良事件增加极少;非雌激素方案间比较数据不足。

核心结论

  • 多数非雌激素疗法是绝经生殖泌尿综合征各症状的有效治疗。
  • 非雌激素方案之间相互比较的数据不足。

研究设计与样本

  • 系统综述,检索MEDLINE、EMBASE、ClinicalTrials.gov和Cochrane数据库,从建库至2021年7月。
  • 双人筛选9131篇摘要,纳入136项符合标准的研究,包括比较性和非比较性研究。
  • 干预和对照限于七种市售且当前使用的产品:阴道脱氢表雄酮、奥培米芬、激光或能量疗法、聚卡波非阴道保湿剂、替勃龙、阴道透明质酸、睾酮。
  • 对照包括局部雌激素、安慰剂、其他非雌激素产品以及不治疗。
  • 系统综述组评估研究质量和证据强度。

主要发现

  • 替代疗法与雌激素或安慰剂相似或更优,不良事件增加极少。
  • 阴道脱氢表雄酮和睾酮观察到剂量反应。
  • 阴道脱氢表雄酮、奥培米芬、铒激光和点阵二氧化碳激光、聚卡波非阴道保湿剂、替勃龙、透明质酸和睾酮均改善萎缩的主观和客观体征。
  • 阴道脱氢表雄酮、奥培米芬、替勃龙、点阵二氧化碳激光、聚卡波非阴道保湿剂和睾酮改善性功能。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 非雌激素方案之间相互比较的数据不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To systematically review the literature and provide clinical practice guidelines regarding various nonestrogen therapies for treatment of genitourinary syndrome of menopause (GSM). DATA SOURCES: MEDLINE, EMBASE, ClinicalTrials.gov , and Cochrane databases were searched from inception to July 2021. We included comparative and noncomparative studies. Interventions and comparators were limited to seven products that are commercially available and currently in use (vaginal dehydroepiandrosterone [DHEA], ospemifene, laser or energy-based therapies, polycarbophil-based vaginal moisturizer, Tibolone, vaginal hyaluronic acid, testosterone). Topical estrogen, placebo, other nonestrogen products, as well as no treatment were considered as comparators. METHODS OF STUDY SELECTION: We double-screened 9,131 abstracts and identified 136 studies that met our criteria. Studies were assessed for quality and strength of evidence by the systematic review group. TABULATION, INTEGRATION, AND RESULTS: Information regarding the participants, details on the intervention and comparator and outcomes were extracted from the eligible studies. Alternative therapies were similar or superior to estrogen or placebo with minimal increase in adverse events. Dose response was noted with vaginal DHEA and testosterone. Vaginal DHEA, ospemifene, erbium and fractional carbon dioxide (CO 2 ) laser, polycarbophil-based vaginal moisturizer, tibolone, hyaluronic acid, and testosterone all improved subjective and objective signs of atrophy. Vaginal DHEA, ospemifene, tibolone, fractional CO 2 laser, polycarbophil-based vaginal moisturizer, and testosterone improved sexual function. CONCLUSION: Most nonestrogen therapies are effective treatments for the various symptoms of GSM. There are insufficient data to compare nonestrogen options to each other.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Casiano Evans EA, Hobson DTG, Aschkenazi SO, et al. Nonestrogen Therapies for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review. Obstet Gynecol. 2023. PMID: 37543737. doi:10.1097/AOG.0000000000005288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。